Brief: Creso Pharma Says Mernova Secures Cannabis 2.0 Sales License
Nov 3 (Reuters) - Creso Pharma Ltd CPH.AX :
* MERNOVA SECURES CANNABIS 2.0 SALES LICENSE
* UNIT RECEIVED APPROVAL FROM HEALTH CANADA FOR AN AMENDED
LICENCE
PERMITTING SALE OF CANNABIS EXTRACTS, AMONG OTHERS
* LICENCE AMENDMENT BUILDS ON CO'S ORIGINAL SALES LICENCE
FROM
HEALTH CANADA
Source text for Eikon: ID:nASXp0jnn
Further company coverage: CPH.AX
Recent news on Melodiol Global Health
See all newsBrief: Melodiol Global Health Reports Q1 Fy24 Unaudited Revenue Of A$4.8M
Brief: Melodiol Global Health Posts Group Unaudited H1 2024 Revenues Of A$9.3 Mln, Up 33%
Brief: Melodiol Global Health Seeks Trading Halt
Melodiol Global Health gains most in over 7 weeks on Canada asset sale
Brief: Melodiol Global Health Proposes A$12M Cash Asset Sale